...
首页> 外文期刊>Scientific reports. >TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions
【24h】

TRPV4 activates the Cdc42/N-wasp pathway to promote glioblastoma invasion by altering cellular protrusions

机译:TRPV4激活CDC42 / N-WASP途径以通过改变细胞突起来促进胶质母细胞瘤侵袭

获取原文

摘要

The invasion ability of glioblastoma (GBM) causes tumor cells to infiltrate the surrounding brain parenchyma and leads to poor outcomes. Transient receptor potential vanilloid 4 (TRPV4) exhibits a remarkable role in cancer cell motility, but the contribution of TRPV4 to glioblastoma metastasis is not fully understood. Here, we reported that TRPV4 expression was significantly elevated in malignant glioma compared to normal brain and low-grade glioma, and TRPV4 expression was negatively correlated with the prognosis of glioma patients. Functionally, stimulation of TRPV4 promoted glioblastoma cell migration and invasion, and repression of TRPV4 hindered the migration and invasion of glioblastoma cells in vitro. Molecularly, TRPV4 strongly colocalized and interacted with skeletal protein-F-actin at cellular protrusions, and TRPV4 regulated the formation of invadopodia and filopodia in glioblastoma cells. Furthermore, the Cdc42/N-wasp axis mediated the effect of TRPV4-regulated cellular protrusions and invasion. Foremost, TRPV4 inhibitor treatment or downregulation of TRPV4 significantly reduced the invasion-growth of subcutaneously and intracranially transplanted glioblastoma in mice. In conclusion, the TRPV4/Cdc42/wasp signaling axis regulates cellular protrusion formation in glioblastoma cells and influences the invasion-growth phenotype of glioblastoma in vivo. TRPV4 may serve as a prognostic factor and specific therapeutic target for GBM patients.
机译:胶质母细胞瘤(GBM)的侵袭能力导致肿瘤细胞渗透周围的脑疗中,并导致差的结果。瞬态受体潜在的香草素4(TRPV4)在癌细胞运动中表现出显着作用,但TRPV4对胶质母细胞瘤转移的贡献尚不完全理解。在这里,与正常的脑和低级胶质瘤相比,恶性胶质瘤的TRPV4表达显着升高,并且TRPV4表达与胶质瘤患者的预后呈负相关。在功能上,TRPV4的刺激促进了胶质母细胞瘤细胞迁移和侵袭,并且TRPV4的抑制阻碍了体外胶质母细胞瘤细胞的迁移和侵袭。分子量,TRPV4在细胞突起中与骨骼蛋白-F-肌动蛋白的骨骼蛋白-F-肌动蛋白相互作用,TRPV4调节植物母细胞瘤细胞中的invidopodia和箔的形成。此外,CDC42 / N-WA-WASP轴介导TRPV4调节细胞突起和侵袭的影响。 TRPV4抑制剂治疗或TRPV4的下调显着降低了小鼠中皮下和膀胱内移植的胶质母细胞瘤的侵袭生长。总之,TRPV4 / CDC42 / WASP信号轴调节胶质母细胞瘤细胞中的细胞突起形成,并影响体内胶质母细胞瘤的侵袭生长表型。 TRPV4可以作为GBM患者的预后因素和特异性治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号